208
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Open-label study to evaluate the treatment continuation rate after a dose reduction of lubiprostone due to onset of adverse events

, , , , &
Pages 333-342 | Received 15 Sep 2020, Accepted 05 Oct 2020, Published online: 18 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hiroyuki Ohbayashi, Yasuo Sato, Mari Kiuchi, Atsushi Nagazumi, Takumi Kanzo & Takazumi Kimura. (2022) Analysis of the impact on efficacy of lubiprostone dose reduction to manage adverse events in the treatment of chronic constipation in Japan. Expert Review of Gastroenterology & Hepatology 16:8, pages 809-817.
Read now

Articles from other publishers (1)

Masaki Maruyama, Suguru Miida, Toshihiro Sato, Takazumi Kimura, Azuma Watanabe, Hideo Watanabe, Masafumi Nishizawa, Kyohei Horikawa, Takahiro Kajiwara, Yusuke Karasawa, Yuko Hasebe, Kazutaka Nozawa & Shuji Terai. (2023) Effectiveness and safety of lubiprostone after switching from stimulant laxatives in elderly patients with chronic constipation. JGH Open.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.